Description
This assay uses the Luminex® 200™ platform.
Attention Clinicians! Our Complement Profile 13-plex panel is now available for clinical diagnostics under CLIA regulation as a Laboratory Developed Test (LDT). This panel includes two simultaneous assays to assess for acute phase inflammatory detection. For details and to enhance your diagnostic capabilities, visit our patient diagnostics webpage. Reference intervals are available for PLASMA-EDTA samples.
Consider this assay for targeted analysis of key complement components and regulators. The Human Complement Expanded Panel 1 9-Plex Discovery Assay® Array is designed to measure critical complement proteins involved in immune regulation and inflammation. The complement system is believed to be crucial in various immune-related diseases like asthma and sepsis, autoimmune disorders including systemic lupus erythematosus and rheumatoid arthritis, as well as in neurological conditions such as Alzheimer’s Disease and spinal cord injuries.
Ideal for studying diseases involving complement dysregulation, such as systemic lupus erythematosus or age-related macular degeneration, this assay provides insights into the roles of proteins like Complement C5a and Mannose-Binding Lectin.
For a more comprehensive profile, consider running on our Human Complement 15-Plex Discovery Assay® Array (HDCMP15) which contains 15 biomarkers.
Discover the power of precision with our assay, expertly designed for the Luminex® 200™ platform. This cutting-edge technology enables the simultaneous detection of multiple biomarkers from a minimal single sample, delivering comprehensive insights with unmatched efficiency. Streamline your research and unlock a new level of detail with our advanced multiplex assay solution.
Click here for information on shipping biological samples for Discovery Assays